← Back to screener

ClearPoint Neuro, Inc. CLPT

Rank #2402 · Nasdaq · $0.3B market cap
⚠ Going-concern flag — the auditor (Cherry Bekaert LLP) raised substantial doubt about this company's ability to continue operating in the latest filing. Read the actual filing before drawing conclusions.
Score
20.7
P/E
-16.9
P/B
15.11
ROE
-89.3%
Op. Margin
-62.9%
Debt Ratio
65%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★☆☆☆☆
Poor

P/E -16.9x, P/B 15.11x. Ranks in the top 83% of the universe.

Profitability ★☆☆☆☆
Poor

ROE -89.3%. Ranks in the top 90% of the universe.

Safety ★★★★☆
Good

Debt ratio 65%. Ranks in the top 28% of the universe.

Growth ★★★★☆
Excellent

Revenue growth of 31.0% year over year. Ranks in the top 12% of the universe.

Safety is the relative strength · Valuation is the relative weakness (relative to this universe).

Financials annual, from SEC 10-K filings

FYRevenueOp. IncomeNet IncomeEquityOp. Margin%Debt%
2012$0.0B$-0.0B$-0.0B$-0.0B-356.5-252
2013$0.0B$-0.0B$-0.0B$-0.0B-61.9-61
2014$0.0B$-0.0B$-0.0B$-0.0B-190.2-200
2015$0.0B$-0.0B$-0.0B$-0.0B-147.6-197
2016$0.0B$-0.0B$-0.0B$-0.0B-195.3-11879
2017$0.0B$-0.0B$-0.0B$-0.0B-130.3-412
2018$0.0B$-0.0B$-0.0B$-0.0B-85.9-1067
2019$0.0B$-0.0B$-0.0B$0.0B-71.4109
2020$0.0B$-0.0B$-0.0B$0.0B-41.0486
2021$0.0B$-0.0B$-0.0B$0.0B-48.5592
2022$0.0B$-0.0B$-0.0B$0.0B-82.1707
2023$0.0B$-0.0B$-0.0B$0.0B-79.538
2024$0.0B$-0.0B$-0.0B$0.0B-93.758
2025$0.0B$-0.0B$-0.0B$0.0B-62.965

← See the full screener